Revisión
Etanercept en el tratamiento de la artritis psoriásica
Etanercept in the Treatment of Psoriatic Arthritis
Leído
13127
Vecesse ha leído el artículo
3201
Total PDF
9926
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 262 | 20 | 282 |
| 2025 5 | 527 | 28 | 555 |
| 2025 4 | 477 | 30 | 507 |
| 2025 3 | 565 | 33 | 598 |
| 2025 2 | 410 | 37 | 447 |
| 2025 1 | 301 | 30 | 331 |
| 2024 12 | 269 | 30 | 299 |
| 2024 11 | 242 | 61 | 303 |
| 2024 10 | 155 | 54 | 209 |
| 2024 9 | 160 | 23 | 183 |
| 2024 8 | 240 | 75 | 315 |
| 2024 7 | 287 | 33 | 320 |
| 2024 6 | 224 | 33 | 257 |
| 2024 5 | 195 | 39 | 234 |
| 2024 4 | 188 | 33 | 221 |
| 2024 3 | 198 | 38 | 236 |
| 2024 2 | 240 | 41 | 281 |
| 2024 1 | 199 | 28 | 227 |
| 2023 12 | 151 | 31 | 182 |
| 2023 11 | 210 | 50 | 260 |
| 2023 10 | 125 | 33 | 158 |
| 2023 9 | 151 | 38 | 189 |
| 2023 8 | 176 | 11 | 187 |
| 2023 7 | 119 | 38 | 157 |
| 2023 6 | 80 | 26 | 106 |
| 2023 5 | 101 | 30 | 131 |
| 2023 4 | 96 | 27 | 123 |
| 2023 3 | 113 | 27 | 140 |
| 2023 2 | 89 | 30 | 119 |
| 2022 1 | 74 | 35 | 109 |
| 2022 12 | 80 | 29 | 109 |
| 2022 11 | 93 | 63 | 156 |
| 2022 10 | 70 | 69 | 139 |
| 2022 9 | 77 | 46 | 123 |
| 2022 8 | 76 | 52 | 128 |
| 2022 7 | 112 | 52 | 164 |
| 2022 6 | 90 | 33 | 123 |
| 2022 5 | 85 | 44 | 129 |
| 2022 4 | 76 | 49 | 125 |
| 2022 3 | 79 | 59 | 138 |
| 2022 2 | 93 | 37 | 130 |
| 2021 1 | 66 | 47 | 113 |
| 2021 12 | 69 | 45 | 114 |
| 2021 11 | 55 | 46 | 101 |
| 2021 10 | 59 | 55 | 114 |
| 2021 9 | 68 | 39 | 107 |
| 2021 8 | 55 | 40 | 95 |
| 2021 7 | 58 | 49 | 107 |
| 2021 6 | 81 | 44 | 125 |
| 2021 5 | 85 | 35 | 120 |
| 2021 4 | 215 | 108 | 323 |
| 2021 3 | 125 | 35 | 160 |
| 2021 2 | 81 | 31 | 112 |
| 2020 1 | 61 | 33 | 94 |
| 2020 12 | 70 | 36 | 106 |
| 2020 11 | 67 | 33 | 100 |
| 2020 10 | 68 | 22 | 90 |
| 2020 9 | 63 | 26 | 89 |
| 2020 8 | 30 | 27 | 57 |
| 2020 7 | 50 | 21 | 71 |
| 2020 6 | 41 | 26 | 67 |
| 2020 5 | 56 | 29 | 85 |
| 2020 4 | 71 | 22 | 93 |
| 2020 3 | 56 | 25 | 81 |
| 2020 2 | 10 | 1 | 11 |
| 2020 1 | 4 | 5 | 9 |
| 2019 12 | 9 | 5 | 14 |
| 2019 11 | 3 | 4 | 7 |
| 2019 10 | 1 | 6 | 7 |
| 2019 9 | 3 | 5 | 8 |
| 2019 8 | 4 | 3 | 7 |
| 2019 7 | 4 | 5 | 9 |
| 2019 6 | 5 | 19 | 24 |
| 2019 5 | 9 | 54 | 63 |
| 2019 4 | 19 | 39 | 58 |
| 2019 3 | 5 | 16 | 21 |
| 2019 2 | 4 | 13 | 17 |
| 2019 1 | 12 | 11 | 23 |
| 2018 12 | 3 | 7 | 10 |
| 2018 11 | 6 | 5 | 11 |
| 2018 10 | 3 | 3 | 6 |
| 2018 9 | 3 | 10 | 13 |
| 2018 8 | 1 | 21 | 22 |
| 2018 7 | 0 | 21 | 21 |
| 2018 6 | 0 | 23 | 23 |
| 2018 5 | 1 | 21 | 22 |
| 2018 4 | 3 | 18 | 21 |
| 2018 3 | 0 | 11 | 11 |
| 2018 2 | 42 | 10 | 52 |
| 2018 1 | 53 | 17 | 70 |
| 2017 12 | 45 | 17 | 62 |
| 2017 11 | 48 | 29 | 77 |
| 2017 10 | 33 | 21 | 54 |
| 2017 9 | 28 | 21 | 49 |
| 2017 8 | 31 | 12 | 43 |
| 2017 7 | 34 | 19 | 53 |
| 2017 6 | 36 | 33 | 69 |
| 2017 5 | 24 | 20 | 44 |
| 2017 4 | 12 | 1 | 13 |
| 2017 3 | 8 | 0 | 8 |
| 2017 2 | 7 | 2 | 9 |
| 2016 1 | 6 | 0 | 6 |
| 2016 12 | 11 | 5 | 16 |
| 2016 11 | 11 | 16 | 27 |
| 2016 10 | 9 | 7 | 16 |
| 2016 9 | 1 | 14 | 15 |
| 2016 8 | 1 | 13 | 14 |
| 2016 7 | 8 | 8 | 16 |
| 2016 6 | 14 | 11 | 25 |
| 2016 5 | 17 | 5 | 22 |
| 2016 4 | 11 | 1 | 12 |
| 2016 3 | 12 | 1 | 13 |
| 2016 2 | 12 | 14 | 26 |
| 2015 1 | 12 | 21 | 33 |
| 2015 12 | 15 | 18 | 33 |
| 2015 11 | 20 | 8 | 28 |
| 2015 10 | 0 | 3 | 3 |
| 2015 9 | 0 | 8 | 8 |
| 2015 8 | 0 | 5 | 5 |
| 2015 7 | 11 | 2 | 13 |
| 2015 6 | 21 | 14 | 35 |
| 2015 5 | 16 | 50 | 66 |
Mostrar todo
